{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-075191","form_type":"8-K","ticker":"RCEL","cik":"0001762303","company_name":"AVITA Medical, Inc.","filed_at":"2023-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.453031+00:00","generated_at":"2026-06-17T22:23:52.761904+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"AVITA Medical appoints Cary Vance to Board of Directors, effective April 1, 2023","bullets":["Cary Vance appointed as non-executive director, effective April 1, 2023, serving until 2023 Annual Meeting.","Compensation: $70,000 annual cash, initial $210,000 stock grant (30% options, 70% RSUs), and $105,000 annual equity, subject to shareholder approval.","Vance has over 25 years healthcare leadership, currently President/CEO of Titan Medical; prior roles include Hansen Medical, Covidien, and GE Healthcare.","Board determined Vance meets independence standards; no material relationships or arrangements with the company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-075191","json":"https://secwatch.observer/filing/0001193125-23-075191.json","markdown":"https://secwatch.observer/filing/0001193125-23-075191.md","text":"https://secwatch.observer/filing/0001193125-23-075191.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1762303/000119312523075191/0001193125-23-075191-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1762303/000119312523075191/d467079d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T22:23:52.761904+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4b8bb16497","claim":"Cary Vance was appointed as Director at AVITA Medical, Inc..","evidence_excerpt":"On March 16, 2023, AVITA Medical, Inc. (the “Company”) issued a press release announcing the appointment of Cary Vance to its Board of Directors (the “Board”), effective April 1, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1762303/000119312523075191/0001193125-23-075191-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}